Tonix Pharmaceuticals Holding (TNXP) Payables (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Payables for 17 years, with the latest figure at $9.1 million in Q2 2026.

• On a quarterly basis, Payables rose 16.29% year-over-year to $9.1 million in Q2 2026; TTM through Jun 2026 was $9.1 million, a 16.29% increase from a year earlier, with the FY2025 full-year figure at $8.1 million, up 78.49% from the prior year.
• Payables was $9.1 million for Q2 2026 at Tonix Pharmaceuticals Holding, down from $9.6 million in the prior quarter.
• The five-year high for Payables was $10.4 million in Q2 2024, with the low at $3.8 million in Q4 2023.
• Average Payables over 5 years is $7.3 million, with a median of $7.9 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Payables jumped 228.68% in 2022, then plunged 53.12% in 2023.
• Over 5 years, Payables stood at $8.1 million in 2022, then slumped by 53.12% to $3.8 million in 2023, then gained by 20.2% to $4.5 million in 2024, then soared by 78.49% to $8.1 million in 2025, then grew by 11.55% to $9.1 million in 2026.
• The last three Payables figures came in at $9.1 million (Q2 2026), $9.6 million (Q1 2026), and $8.1 million (Q4 2025), per Business Quant data.